Related Experiment Videos
Hurthle cell carcinoma arising from thyroid papillary carcinoma
L Jonathan Zwi1, Virginia A LiVolsi
1Department of Pathology, Faculty of Medicine and Health Science, University of Auckland, Auckland, New Zealand. j.zwi@auckland.ac.nz
Endocrine Pathology
|November 26, 2002
Summary
This study presents a rare case of thyroid cancer where metastatic papillary thyroid carcinoma in lymph nodes also contained Hurthle cell carcinoma. This finding suggests a potential link between these thyroid cancer subtypes.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Hurthle cell carcinoma (HCC) is typically classified as a variant of follicular thyroid carcinoma.
- Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy.
- The distinct origins and characteristics of HCC and PTC have historically suggested separate classifications.
Observation:
- A case study involving a small, solitary, usual-type papillary thyroid carcinoma.
- Metastatic tumor was identified in the cervical lymph nodes.
- Microscopic examination revealed the lymph node metastasis comprised both tall-cell papillary carcinoma and Hurthle cell carcinoma components.
Findings:
- The co-occurrence of distinct PTC and HCC morphologies within a single lymph node metastasis is a novel observation.
- This finding challenges the traditional separation of these thyroid cancer subtypes.
- The presence of both tumor types in metastasis suggests a potential shared origin or differentiation pathway.
Implications:
- Suggests a closer relationship between papillary and Hurthle cell thyroid tumors than previously understood.
- May necessitate re-evaluation of current thyroid cancer classification systems.
- Could impact diagnostic approaches and therapeutic strategies for thyroid malignancies.